Boston Scientific stock rises as BTIG reiterates Buy rating after strong Q3
PositiveFinancial Markets

Boston Scientific's stock has seen a notable rise following BTIG's decision to reiterate a Buy rating after the company reported strong third-quarter results. This positive endorsement from BTIG highlights investor confidence in Boston Scientific's performance and growth potential, making it a significant development for shareholders and market watchers alike.
— Curated by the World Pulse Now AI Editorial System